The United States may not need AstraZeneca’s COVID-19 vaccine, even if it wins U.S. regulatory approval, says Anthony Fauci on Friday.

'US may not need AstraZeneca Covid vaccine', says Anthony Fauci

US&nbsp;top infectious disease specialist Dr. Anthony&nbsp;Fauci is once again in the news regarding his statement on the&nbsp;new <a href="https://www.wionews.com/topics/coronavirus-vaccine">coronavirus&nbsp;vaccine</a>.

The news comes as the winter surge in cases rages across the country, where the virus has claimed more than 320,000 lives and is on course to be the third leading cause of death in the year.

Fauci&nbsp;has admitted that he lied to Americans about herd immunity to manipulate their acceptance of a new coronavirus&nbsp;vaccine.

Also read:&nbsp;<a href="https://www.wionews.com/world/millions-of-us-vaccine-doses-sit-on-ice-putting-2020-goal-in-doubt-352048" hreflang="en">Millions of US vaccine doses sit on ice, putting 2020 goal in doubt</a>

Herd immunity, or the percentage of a population that acquires resistance to the coronavirus through infection or vaccination, has been widely estimated at roughly 60 to 70 percent for the coronavirus since the start of the pandemic.

When pressed to answer about the issue, Fauci&nbsp;admitted in a new interview that he’s been intentionally moving the goalposts on his recommendations regarding herd immunity based on what he thinks the American people are ready to hear.

“When polls said only about half of all Americans would take a vaccine, I was saying herd immunity would take 70 to 75 percent,”&nbsp;Fauci said.&nbsp;

Fauci&nbsp;said he hesitated to state a number as high as 90 per cent&nbsp;weeks ago because many Americans still seemed skeptical about vaccines.

The 79-year-old, who continues to practice as a physician, was among the first Americans to receive injections developed by Moderna and the NIH's National Institute of Allergies and Infectious Diseases (NIAID), which he has led since 1984.

US top infectious disease specialist Dr. Anthony Fauci is once again in the news regarding his statement on the new coronavirus vaccine. The news comes as the winter surge in cases rages across the country, where the virus has claimed more than 320,000 lives and is on course to be the third leading cause of death in the year.

US top infectious disease specialist Dr. Anthony Fauci is once again in the news regarding his statement on the new coronavirus vaccine. The news comes as the winter surge in cases rages across the country, where the virus has claimed more than 320,000 lives and is on course to be the third leading cause of death in the year. Fauci has admitted that he lied to Americans about herd immunity to manipulate their acceptance of a new coronavirus vaccine. Also read: Millions of US vaccine doses sit on ice, putting 2020 goal in doubt Herd immunity, or the percentage of a population that acquires resistance to the coronavirus through infection or vaccination, has been widely estimated at roughly 60 to 70 percent for the coronavirus since the start of the pandemic. When pressed to answer about the issue, Fauci admitted in a new interview that he’s been intentionally moving the goalposts on his recommendations regarding herd immunity based on what he thinks the American people are ready to hear. “When polls said only about half of all Americans would take a vaccine, I was saying herd immunity would take 70 to 75 percent,” Fauci said. Fauci said he hesitated to state a number as high as 90 per cent weeks ago because many Americans still seemed skeptical about vaccines. The 79-year-old, who continues to practice as a physician, was among the first Americans to receive injections developed by Moderna and the NIH's National Institute of Allergies and Infectious Diseases (NIAID), which he has led since 1984.

Did US infectious disease expert Fauci lie or move goalposts on virus vaccine?

'The Christmas holiday season could pose greater risks than Thanksgiving when it comes to spreading the coronavirus', says Anthony Fauci.

Anthony Fauci predicts COVID-19 pandemic to likely improve by Christmas